Importantly, patients with high PLOD3 expression showed significantly shorter OS (P = 0.033), FP (P = 0.004), and PPS (P < 0.001) in HER-2-positive subgroup in GC patients according to Kaplan-Meier Plot database (Fig. 4C). This evidence concerns the gene PLOD3 and gastric cancer.